FOXO:NYE-FOXO Technologies Inc. (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 0.2665

Change

0.00 (-1.30)%

Market Cap

N/A

Volume

7.45M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-23 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
SOLV Solventum Corp.

-0.06 (-0.08%)

USD 10.78B
DOCS Doximity Inc

-0.36 (-0.64%)

USD 9.97B
WEAV Weave Communications Inc

+0.15 (+0.95%)

USD 1.13B
MPLN MultiPlan Corporation

-0.18 (-1.13%)

USD 0.23B
AMWL American Well Corp

+0.68 (+6.61%)

USD 0.11B
OWLT Owlet Inc

-0.01 (-0.22%)

USD 0.07B
PHR Phreesia Inc

+0.06 (+0.22%)

N/A
VEEV Veeva Systems Inc Class A

-6.10 (-2.66%)

N/A
EVH Evolent Health Inc

+0.18 (+1.80%)

N/A
TDOC Teladoc Inc

+0.26 (+2.63%)

N/A

ETFs Containing FOXO

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -8.51% 18% F 4% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.51% 18% F 4% F
Trailing 12 Months  
Capital Gain -6.39% 60% D- 19% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -6.39% 60% D- 16% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -7.06% 40% F 9% A-
Dividend Return -7.06% 40% F 7% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 233.18% 30% F 4% F
Risk Adjusted Return -3.03% 50% F 19% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector